Johnson & Johnson CEO Sells Shares Worth Approximately $30 Million Through Spouse's Account

Joaquin Duato, CEO and Board Chair of Johnson & Johnson (NYSE: JNJ), sold common shares of the company in two separate transactions on January 26 via an account held in his spouse’s name, generating roughly $22 million (approximately ₩300 billion). According to the SEC filing, the shares were sold at about $221 each. Even after these transactions, Duato and his spouse continue to hold a substantial stake in Johnson & Johnson.

On February 2, Johnson & Johnson announced it will participate in a fireside chat on March 3 at the 46th Annual TD Cowen Health Care Conference. Over the past year, the stock has climbed about 50% since its spin-off, and the company has maintained its shareholder-return policy, most recently declaring a $1.30 per-share cash dividend.

Headquartered in New Jersey, Johnson & Johnson is a global healthcare conglomerate operating worldwide, with core businesses in pharmaceuticals and medical devices. As CEO and Board Chair, Duato oversees the company’s strategic direction and capital allocation. The recently disclosed share sales were carried out as part of managing his and his family’s holdings and were duly reported to the SEC.